Please ensure Javascript is enabled for purposes of website accessibility
Don't miss
Home / News / AstraZeneca’s Seroquel study found no link to diabetes onset

AstraZeneca’s Seroquel study found no link to diabetes onset

A study by AstraZeneca Plc found "no significant" link between the company's antipsychotic drug Seroquel and the onset of diabetes, an expert witness said at a pre-trial hearing on lawsuits over the product. Dr. Paul D. Woolf, a Philadelphia-based doctor who specializes in treating diabetes, told a judge Thursday that his review of a 2004 AstraZeneca ...